Abstract
Improved techniques in identifying the chromosome changes and the affected genes that are involved in acute leukemias have led to improved treatments for these diseases. Identification of consistent chromosomal changes has allowed us to target the location of particular genes and has enabled us to focus our treatments more specifically to certain subtypes of leukemia. Translocations, in particular, are common cytogenetic abnormalities in human leukemia, and the prevalence of certain types of translocations varies with age. Cancers, lymphomas and leukemias are now known to be genetic diseases and it is recognized that genotype-specific therapies should be used that take into account the genetic alterations of the particular leukemia.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Veldman T, Vignon C, Schrock E, Rowley JD, Ried T . Hidden chromosome abnormalities in haematological malignancies detected by multicenter spectral karyotyping Nat Genet 1997 15: 406–410
Rowley JD, Reshmi S, Carlson K, Roulston D . Spectral karyotype analysis of T-cell acute leukemia Blood 1999 93: 2038–2042
Fleischman EW, Reshmi S, Sokova OI et al. Increased karyotype precision using fluorescence in situ hybridization and spectral karyotyping in patients with myeloid malignancies Cancer Genet Cytogenet 1999 108: 166–170
Carter NP, Ferguson-Smith ME, Affara NA, Briggs H, Ferguson-Smith MA . Study of X chromosome abnormality in XX males using bivariate flow karyotype analysis and flow sorted dot blots Cytometry 1990 11: 202–207
Rowley JD, Golomb HM, Vardiman J, Fukuhara S, Dougherty C, Potter D . Further evidence for a non-random chromosomal abnormality in acute promyelocytic leukemia Int J Cancer 1977 20: 869–872
Grimwade D, Walker H, Oliver F et al. The importance of diagnostic cytogenetics on outcome in AML: analysis of 1612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties Blood 1998 92: 2322–2333
Rowley JD . The critical role of chromosome translocations in human leukemias Annu Rev Genet 1998 32: 495–519
Sakurai M, Swansbury GJ . Fourth International Workshop on Chromosomes in Leukemia 1982: overview of association between chromosome pattern and cell morphology, age, sex, and race Cancer Genet Cytogenet 1984 11: 265–274
Rabbitts TH . Chromosomal translocations in human cancer Nature 1994 372: 143–149
Look TA . Oncogenic transcription factors in human acute leukemia Science 1997 278: 1059–1064
Grimwade D . Howe K, Langabeer S et al. Establishing the presence of the t(15;17) in suspected acute promyelocytic leukaemia: cytogenetic, molecular and PML immunofluorescence assessment of patients entered into the MRC ATRA trial. MRC Adult Leukaemia Working Party Br J Haematol 1996 94: 557–573
Sato Y, Bohlander SK, Kobayashi H et al. Heterogeneity in the breakpoints in balanced rearrangements involving bank 12p13 in hematologic malignancies identified by fluorescence in situ hybridization: TEL (ETV6) is involved in only one half Blood 1997 90: 4886–4893
Rowley JD, Reshmi S, Sobulo O et al. All patients with the t(11;16)(q23;p13.3) that involves MLL and CBP have treatment-related hematologic disorders Blood 1997 90: 535–541
Thirman MJ, Gill HJ, Burnett RC et al. Rearrangement of the MLL gene in acute lymphoblastic and acute myeloid leukemias with 11q23 chromosomal translocations New Engl J Med 1993 329: 909–914
Nucifora G, Dickstein JI, Torbenson V, Roulston D, Rowley JD, Vardiman JW . Correlation between cell morphology and expression of the AML1/ETO chimeric transcript in patients with acute myeloid leukemia without the t(8;21) Leukemia 1994 8: 1533–1538
Warrell RP Jr, He LZ, Richon V, Calleja E, Pandolfi PP . Therapeutic targeting of transcription in acute promyelocytic leukemia by use of an inhibitor of histone deacetylase J Natl Cancer Inst 1998 90: 1621–1625
He LZ, Guidez F, Tribioli C et al. Distinct interactions of PML-RARalpha and PLZF-RARalpha with corepressors determine differential responses to RA in APL Nat Genet 1998 18: 126–135
Wang J, Hoshino T, Redner RL, Kajigaya S, Liu JM . ETO, fusion partner in t(8;21) acute myeloid leukemia, represses transcription by interaction with the human N-CoR/mSin3/HDAC1 complex Proc Natl Acad Sci USA 1998 95: 10860–10865
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Rowley, J. Molecular genetics in acute leukemia. Leukemia 14, 513–517 (2000). https://doi.org/10.1038/sj.leu.2401600
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2401600
Keywords
This article is cited by
-
Clinicopathological impact of CD20 expression in childhood B cell precursor acute lymphoblastic leukemia (BCP-ALL)
Comparative Clinical Pathology (2017)
-
Detection of microvesicle miRNA expression in ALL subtypes and analysis of their functional roles
Journal of Huazhong University of Science and Technology [Medical Sciences] (2014)
-
MLL rearrangements in pediatric acute lymphoblastic and myeloblastic leukemias: MLL specific and lineage specific signatures
BMC Medical Genomics (2009)
-
Treatment of deletion 5q acute myeloid leukemia with lenalidomide
Leukemia (2007)
-
Simultaneous localization of MLL, AF4 and ENL genes in interphase nuclei by 3D-FISH: MLL translocation revisited
BMC Cancer (2006)